» Articles » PMID: 37631950

Impact of a COVID-19 Outbreak in an Elderly Care Home After Primary Vaccination

Abstract

Elderly care home residents are particularly vulnerable to COVID-19 due to immune-senescence, pre-existing medical conditions, and the risk of transmission from staff and visitors. This study aimed to describe the outcomes of a COVID-19 outbreak in a long-term care facility for elderly persons following the initial vaccination. A single-center, retrospective, observational design was used to analyze the variables associated with hospitalization and death rate by logistic regression. Adjusted odds ratios (aOR) and their 95% confidence intervals (CI) were calculated. Sixty-eight residents received the first dose of the COVID-19 vaccine. Despite being negative six days after vaccination, the performance of a second test 4 days later revealed 51 positives (75.0%) among residents and 18 among workers (56.3%). A total of 65 of the 68 residents (95.58%) had positive results with symptoms, whereas 34.9% required hospitalization, and 25.8% died. The best-fitting model to explain the distribution of cases reflects three points at the time of infection.. The time from vaccination to symptom onset explains the hospitalization and mortality rates since a day elapsed halves the risk of hospitalization (aOR = 0.57; CI = 0.38-0.75) and the risk of death by a quarter (aOR = 0.74; CI = 0.63-0.88). Nursing homes present an elevated risk of transmission and severity of SARS-CoV-2 infection. Although vaccination reduces the risk of hospitalization and death, extreme prevention and control measures are essential in these institutions despite the high vaccination coverage.

Citing Articles

Understanding the impact of COVID-19 on quality of life using surveys and Mendelian randomization.

Jiang K, Ji H, Ma L, Zhao Z, Zhao Y, Feng J Sci Rep. 2024; 14(1):30929.

PMID: 39730560 PMC: 11680575. DOI: 10.1038/s41598-024-81579-5.


Cycle Threshold Values of SARS-CoV-2 RT-PCR during Outbreaks in Nursing Homes: A Retrospective Cohort Study.

Gasco-Laborda J, Gil-Fortuno M, Tirado-Balaguer M, Meseguer-Ferrer N, Sabalza-Baztan O, Perez-Olaso O Epidemiologia (Basel). 2024; 5(4):658-668.

PMID: 39449389 PMC: 11503345. DOI: 10.3390/epidemiologia5040046.


Epidemiology of COVID-19 outbreaks in aged care facilities during postvaccine period: a systematic review and meta-analysis.

Hashan M, Smoll N, Chapman G, King C, Walker J, Kirk M BMJ Open. 2024; 14(3):e073555.

PMID: 38485480 PMC: 10941149. DOI: 10.1136/bmjopen-2023-073555.

References
1.
van Ewijk C, Hazelhorst E, Hahne S, Knol M . COVID-19 outbreak in an elderly care home: Very low vaccine effectiveness and late impact of booster vaccination campaign. Vaccine. 2022; 40(46):6664-6669. PMC: 9531647. DOI: 10.1016/j.vaccine.2022.09.080. View

2.
Iacobucci G, Mahase E . Covid-19 vaccination: What's the evidence for extending the dosing interval?. BMJ. 2021; 372:n18. DOI: 10.1136/bmj.n18. View

3.
Camara J, Gonzalez-Diaz A, Barrabeig I, Fernandez-Huerta M, Calatayud L, Niubo J . SARS-CoV-2 outbreak in a nursing home after vaccination with BNT162b2: A role for the quantification of circulating antibodies. Vaccine. 2022; 40(18):2531-2534. PMC: 8920877. DOI: 10.1016/j.vaccine.2022.03.026. View

4.
Dagan N, Barda N, Kepten E, Miron O, Perchik S, Katz M . BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. N Engl J Med. 2021; 384(15):1412-1423. PMC: 7944975. DOI: 10.1056/NEJMoa2101765. View

5.
Bernadou A, Bouges S, Catroux M, Rigaux J, Laland C, Leveque N . High impact of COVID-19 outbreak in a nursing home in the Nouvelle-Aquitaine region, France, March to April 2020. BMC Infect Dis. 2021; 21(1):198. PMC: 7897879. DOI: 10.1186/s12879-021-05890-6. View